Publication | Closed Access

Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin

NanomedicineMedicinal ChemistryDrug TargetingPolymer-drug ConjugateMedicineDrug Delivery SystemsAnticancer Drug CisplatinDelivery VehiclesTumor TargetingNano-drug DeliveryDrug Delivery SystemPharmacologyRadiation OncologyActive Component